Tumor suppressor in lung cancer-1 is a prognostic predictor for the recurrence and progression of no

来源 :泌尿生殖肿瘤华夏医学论坛2016暨长城国际泌尿男科转化医学论坛2016 | 被引量 : 0次 | 上传用户:losches
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective: To investigate the relationship between tumor suppressor in lung cancer-1 (TSLC1) expression and clinicopathological characteristics and evaluate its prognostic significance in patients with non-muscle-invasive bladder cancer (NMIBC).
其他文献
会议
会议
Objective: Analyzing the features of transurethral end-fire greenlight photoselective vaporesection of prostate-shovel technique (PVRP-ST) and evaluating the safety and efficacy of transurethral end-f
Objective: Testicular nuclear receptor 4 (TR4) is a member of the nuclear receptor superfamily,which may play key roles to influence the metabolic diseases and prostate tumorigenesis.The purpose of ou
Objective: To investigate the impact of squamous and/ or glandular differentiation on recurrence and progression in patients with non-muscle-invasive urothelial carcinoma of bladder (NMIUCB) following
Objective: This study aimed to determine the expression status of actin-binding protein Girdin in non-muscle invasive bladder cancer (NMIBC) tissues,and to explore the relationships between Girdin exp
Objective: Prostate cancer is the second common malignancies ofmen around the world.According to the database about prostate cancer of our institute,in our study,we will analyses prostate cancer patie
Objective: To explore the feasibility of transurethral resection for the distal ureter and bladder cuff in radical nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma (UUT
Objective: To study the histology and pathology clinical features,diagnosis,identification and treatment of mixed epithelial and stromal tumor of the kidney (MESTK).
Objective: To evaluate the clinical significance of lymphovascular invasion (LVI) on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection